GE to evaluate Global Patient Safety Network

GE Healthcare has launched a 90-day evaluation period for its Global Patient Safety Network, offering hospitals and healthcare professionals an opportunity to connect with local and global peers on improving patient safety initiatives.

Between April and June, the Waukesha, Wis.-based company is inviting providers to participate free of charge in the online community that will allow providers to connect with members of their specialty.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.